GO:0070064 proline-rich region binding explained

GO:0070064 proline-rich region binding is a molecular function term in the Gene Ontology that describes the selective, non-covalent association of a protein or other ligand with a proline-rich region (PRR) of a target protein. PRRs are polypeptide segments in which proline residues are over-represented, often adopting extended polyproline II helices that present shallow, solvent-exposed interaction surfaces rather than deep binding pockets. Because proline lacks a backbone amide hydrogen, PRRs cannot form regular alpha-helices or beta-sheets, and they frequently reside within intrinsically disordered regions that remain accessible for regulated protein-protein interactions. This architecture makes proline-rich region binding a central mechanism for assembling transient signaling complexes, scaffolding enzymes and coupling phosphorylation state to binding affinity. The functional importance of GO:0070064 is best illustrated by the microtubule-associated protein Tau, whose proline-rich region (approximately residues 165-240) mediates interactions with glycans, kinases and microtubules in a phosphorylation-dependent manner. Nuclear magnetic resonance studies have shown that the Tau PRR engages glycan ligands through specific residue contacts, and that this interaction modulates Tau behavior. In living neurons, the phosphorylation state of the Tau PRR acts as a graded rheostat that tunes microtubule binding, linking proline-rich region binding directly to cytoskeletal regulation. Structural work has further resolved how the PRR contributes to Tau function and to the conformational transitions that accompany aggregation. Proline-rich region binding is not limited to Tau. The conserved N-terminal PRR of the alpha-subunit of CAAX-prenyltransferases influences enzyme properties, indicating that PRR-mediated contacts regulate prenylation enzymes. Histidine-proline-rich glycoprotein (HPRG) uses its proline-rich repeats for structure-function relationships in plasma and matrix biology. The c-Cbl oncoprotein relies on proline-rich sequences to recruit SH3-domain partners during ubiquitin-ligand adaptor signaling. More recently, proline-rich region-dependent interactions have been implicated in the segregation of endoplasmic reticulum exit sites for cargo of different sizes. Together, these examples establish GO:0070064 as a broadly relevant molecular function that connects sequence-encoded disorder to cellular decision-making.

In our own words, GO:0070064 proline-rich region binding is the molecular function of selectively and non-covalently binding to a proline-rich region, i.e. a segment of a protein that contains a high proportion of proline residues. The term describes the binding event itself rather than any downstream consequence; it is agnostic as to whether the binding partner is a folded proline-recognition domain (such as an SH3 or WW domain) or another type of ligand, and it does not require that the proline-rich region be intrinsically disordered, although many are.

Proline-rich region binding is important because it converts a simple sequence feature, the over-representation of proline, into a versatile and regulatable protein-interaction platform. Unlike binding events that require a pre-formed pocket, PRR-mediated contacts can be tuned by phosphorylation, glycosylation and conformational equilibria, allowing cells to switch complexes on and off rapidly. This makes GO:0070064 a recurring node in signaling, cytoskeletal regulation and membrane trafficking, and a frequent point of vulnerability in disease.

The following genes and proteins are experimentally linked to proline-rich region binding (GO:0070064) in the verified literature.

Proline-rich region binding is regulated primarily by post-translational modification of the proline-rich region itself, most notably phosphorylation. In living neurons, the phosphorylation state of the Tau PRR provides graded control of microtubule binding, so that the same PRR can shift between low- and high-affinity states depending on kinase and phosphatase activity. Glycan occupancy of Tau PRR2 further modulates PRR interactions, adding a second layer of regulation. For CAAX-prenyltransferases, the conserved N-terminal PRR influences enzyme properties, suggesting that intramolecular or intermolecular PRR contacts can autoregulate catalytic activity. In trafficking, PRR-dependent sorting at endoplasmic reticulum exit sites is regulated by cargo size, indicating that the availability of PRR readers and cargo geometry together set the interaction outcome. Collectively, these mechanisms show that GO:0070064 is not constitutive but is tuned by phosphorylation, glycosylation and compartment-specific partner availability.

The Tau proline-rich region is a hotspot for phosphorylation and interaction changes in tauopathies, and structural work links PRR conformation to Tau function and aggregation. NMR studies show that Tau PRR2 engages glycans, providing a mechanistic route by which proline-rich region binding could influence pathological Tau behavior. In living neurons, PRR phosphorylation grades microtubule binding, so disease-associated phosphorylation changes are expected to perturb cytoskeletal function. Together these findings place GO:0070064 among the molecular functions most directly implicated in Alzheimer disease and related tauopathies.

The c-Cbl oncoprotein uses proline-rich sequences to assemble SH3-domain-containing signaling complexes, and perturbation of these interactions contributes to dysregulated ubiquitin-ligand and receptor tyrosine kinase signaling. Because many oncogenic adaptors and kinases contain SH3 domains that read proline-rich motifs, proline-rich region binding is a recurring node in cancer signaling networks. Targeting PRR-mediated interactions is therefore an active conceptual avenue for modulating oncogenic complexes.

Proline-rich region-dependent mechanisms contribute to the segregation of endoplasmic reticulum exit sites for secretion according to cargo size, so defects in PRR recognition could impair secretory fidelity. This links GO:0070064 to the broader biology of ER exit site organization and to diseases in which secretory trafficking is perturbed. Although direct human disease mutations in this pathway remain to be fully defined, the cell-biological evidence supports a role for PRR binding in secretory homeostasis.

The conserved N-terminal PRR of the CAAX-prenyltransferase alpha-subunit affects enzyme properties, connecting proline-rich region binding to prenylation-dependent processes such as Ras and Rho family function. Histidine-proline-rich glycoprotein structure-function relationships further illustrate how PRR-containing proteins participate in plasma and matrix biology relevant to vascular and inflammatory contexts. These examples indicate that GO:0070064 has disease relevance beyond neurodegeneration and cancer.

Solution NMR is the method of choice for resolving how a proline-rich region contacts its ligand, because PRRs are often disordered and resist crystallization. NMR studies of Tau PRR2 have defined glycan interaction surfaces and residue-level contacts, providing direct evidence for GO:0070064. Similar approaches can be applied to other PRR-containing proteins to map interaction interfaces.

Cryo-EM and crystallography, combined with NMR, have provided structural insights into the role of the Tau PRR in function and aggregation. These structures reveal how PRR conformation couples to adjacent folded domains and to disease-relevant transitions. Structural work is therefore essential for interpreting the functional consequences of proline-rich region binding.

Live-cell imaging of Tau in neurons has been used to show that the phosphorylation state of the PRR provides graded regulation of microtubule binding. This approach measures binding in a physiological context rather than in vitro, capturing the dynamic range of GO:0070064. Imaging can be combined with phospho-mutant knock-ins to test causality.

Affinity purification and mass spectrometry can identify the partners recruited through a proline-rich region, as illustrated by studies of PRR-dependent trafficking and adaptor signaling. When coupled to CRISPR-engineered tagged knock-in lines, proteomics can distinguish PRR-dependent from PRR-independent interactions. This is a scalable route to defining the interaction network of GO:0070064.

Researchers studying proline-rich region binding-related genes often need to determine whether a candidate gene is causally involved in a specific interaction, pathway or disease phenotype. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to causation, using knockout, point-mutation, knock-in, tagged knock-in and overexpression strategies tailored to proline-rich region biology.

GO:0070064 proline-rich region binding captures a fundamental and widespread molecular function in which proline-rich segments of proteins serve as tunable interaction platforms. The verified literature shows that this function operates in cytoskeletal regulation through Tau, in enzyme regulation through CAAX-prenyltransferases, in plasma and matrix biology through HPRG, in signaling through c-Cbl and SH3-domain adaptors, and in secretory trafficking at endoplasmic reticulum exit sites. Because PRR interactions are frequently regulated by phosphorylation and can be disrupted by point mutations, they are highly amenable to CRISPR-based causal dissection. For researchers, the practical implication is that proline-rich region binding should be treated as a mechanistic hypothesis to be tested with matched knockout, point-mutation, knock-in and overexpression models, combined with structural and live-cell readouts. EDITGENE supports this workflow end to end, from model generation to screening and bioinformatic interpretation.